Invited commentary  by Clair, Daniel G.
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 5 Clair 1101were derived from a commercial company and were often
collected by sales and product persons employed by this
company. There was no doctor or investigator accountabil-
ity for the accuracy of procedure reporting of most of the
cases. Hence, despite an aggressive effort to capture all
misaligned deployment events, this report may represent an
under reporting. Most misalignment events have no imme-
diate adverse clinical sequel, so not all are reported or
recognized. Because imaging studies were not yet available
for most of the events reported in the postapproval phase of
the data collection process, a complete analysis of the causes
of those misalignment events has not yet been possible. In
addition, no data are currently available on the long-term
outcome of patients with these misaligned grafts.
CONCLUSION
Based on a thorough review of all reported cases of
misaligned deployment of the Talent TSG, we believe that
it is an unusual phenomenon that tends to occur in the
context of specific well-defined circumstances and rarely
has immediate clinical implications. It often occurs with the
use of larger-diameter grafts placed in tortuous aortic anat-
omy. Attention to deployment technique along with
proper patient selection, perioperative imaging, and case
planning can help to identify the patients in whom mis-
aligned deployment is more likely to occur and prepare
physicians for using effective measures to prevent these
events. Future device development is underway to prevent
this phenomenon in the form of a “tip capture,” which
involves constriction of the proximal bare stent until the
entire device is deployed.
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The article by Kasirajan et al highlights misalignment of the
Talent Thoracic Stent Graft System (Medtronic Vascular, Santa
Rosa, Calif). As they note in their article, misalignment can and
does occur with all of the currently available thoracic stent graft
systems. It is likely that this evaluation significantly underestimates
the occurrence of this phenomenon, and it is clear that we do not
have a real understanding of why this occurs in each instance.
Misalignment, as defined by a lack of alignment of the stent
graft parallel to the walls of the aorta, occurs muchmore frequently
than noted; however, confining the definition, as the authors have
done, to “retroflexed” proximal stents, which could be considered
severe misalignment, occurs much less frequently. There are sev-
eral intriguing issues regarding the findings and several important
points the authors note as well.
The incidence of this event appears to be much more frequent
in the United States than in Europe, occurring in almost 2% of
patients (1.7% per patient calculation) in the United States com-
mercial sales. Even this incidence is probably under-representing
the true incidence. In addition, although the authors note that this
is more common to occur with larger graft sizes, without knowingsimply increased graft size as the issue. There is no information
regarding the degree of over-sizing and no information regarding
patient features alone, which may be responsible for these issues.
Finally, although limited sequelae have been noted in these cases,
the long-term events for these patients have not been defined, and
it remains to be seen how individuals with these devices will fare,
and in fact, how the devices themselves will fare when deployed in
a manner that is completely outside the anatomic situation for
which they were designed.
Significantly, the authors have pointed out a number of tips
that can be used during deployment that can help to decrease the
occurrence of this problem. Although it is important for any
physician deploying implantable devices to understand how the
device works and how the deployment system works, it is likely
more important to understand how the device and its deployment
mechanism fail and how this can be avoided or managed. The tips
the authors have outlined here should be heeded by those using
these devices, especially in tortuous aortic anatomy. Similar under-
standing of deployment mechanics and the failure modes of the
deployment mechanics would be helpful to understand for all
endovascular grafts, and it is only through publications such as this
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fully, averted.
On a final note, it is important to note that Medtronic has
recognized the deficiencies related to its current deployment
mechanism and has re-engineered its system to attempt to obviate
these problems. Here again, clinician input and exchange are andevice design and providing important feedback to device manu-
facturers regarding these concerns. Reports like this regarding new
technologies and identification of problems and difficulties along
withmethods of avoiding or preventing them are an important part
of the medical and surgical literature and provide much needed
information that ultimately benefits patients, clinicians, and deviceimportant part of the process highlighting shortcomings of current manufacturers.
